Substance Use Disorder

Processed foods, also described as “junk-food,” are often reported to be highly addictive in humans-leading to behavioral effects such as overeating, eating compulsions, and loss of control.

A radical and urgent perspective about the realities of climate change.

Judgements and settlements are starting in Oklahoma against various pharmaceutical companies for their alleged roles in that state’s opioid crisis. Who would be the beneficiaries of these funds?

This overview addresses two medications for analgesia of chronic benign pain, both of which have substance abuse risks themselves.

Technology addiction and screen time are topics of increased concern, but often the discussion does not focus on solutions. In this video, John Torous, MD discusses a new randomized clinical trial that explores the efficacy of CBT to guide patients in their recovery.

Technology will have an enormous impact on mental health, but perhaps not as soon as people think. Some of the earliest technologies to be deployed into clinical practice will help to augment clinicians, empower patients, and enable a data-driven approach to psychiatry.

The use of e-cigarettes may precede cigarette smoking as well as the use of other substances, especially among young people.

Those last years of the Communist regime were met with literal darkness, collective trauma, and lack of food and free speech. Yet the peoples’ wicked, clandestine sense of humor cut through the despair and resilience rose from the ashes.

Prescription drug misuse in adolescents is source driven and asking frequency questions identifies problematic substance use are some of the more significant findings.

Cannabis is a widely used drug of abuse in adolescents. With legalization of marijuana, adolescent cannabis use may increase substantially.

Increased addiction risk in children of incarcerated parents; reinforcement-based interventions may decrease drug abuse; and other key findings are summarized here.

What happens when your patient uses cannabinoid compounds for pain, especially if there are currently taking opioids? Just in time for Pain Awareness Month, the results from these new studies provide insights and guidance.

A recent report provides a global update on the growth of drug use and its consequences.

The cannabinoids (particularly CBD) have been hailed as non-addictive solutions to using escalating doses of opioids for chronic pain. More in this research update.

An interplay between genetic and early environmental factors contributes to the development of substance abuse.

New findings on a not-so-new epidemic have two key implications for psychiatrists.

Medical professionals don’t want to prescribe too many pain killers, which may contribute to the epidemic of opioid misuse, yet they don’t want patients to needlessly suffer.

Cocaine, psychostimulant, and opioid deaths continue to climb, and polysubstance opioid overdose deaths outnumber opioid-only deaths-these and other reports headline the latest developments.

How many of us, during clinical encounters with patients, focus on their families, their social communities, their sources of human contact and support?

Our job as clinicians, our privilege, is to help our patients stay alive until they can engage and benefit from good treatment.

Despite growing awareness and dangers of opioid diversion, misuse among the aging population has skyrocketed.

On December 27, I learned that my pregnancy would not come to fruition with a baby for me. The healing process begins for me as it has for countless women before me. More in Portrait of a Psychiatrist.

A quick overview of the latest advances in substance use and abuse research.

A small exploratory study provides a first look at the role of social relationships in maintaining sobriety.

"He'll just have to hit bottom." That bit of outdated advice can be terrifying. How do clinicians trying to help the person with an addiction who refuses to set foot in our office render assistance?

Opioids, suicide, and Alzheimer disease all play a large role in the life expectancy drop reported by the CDC.

Should hallucinogens such as ketamine, MDMA, psilocybin, and LSD be considered as treatment options for patients with mental illness?

Symptoms of alcohol and drug intoxication and withdrawal may resemble symptoms of bipolar disorder, making it difficult to diagnose and treat.

Seven common questions about addiction clinicians regularly hear-as well as the answers.